Zuma-4 Phase 1 Long-Term Results: Kte-X19 Chimeric Antigen Receptor T-Cell Therapy In Pediatric/Adolescent Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
KTE-X19
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Zuma-4 Phase 1 Long-Term Results: Kte-X19 Chimeric Antigen Receptor T-Cell Therapy In Pediatric/Adolescent Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia ### Output: KTE-X19